SoujanyaRoll no: 36

NIMRA Womens College of Engineering

a presentation on Dr. Reddy's Laboratories

Ltd.Laboratories private limited

GIST OF THE COMPANYDr. Reddy's Laboratories Ltd.

Type : Public

Industry : Pharmaceuticals

Founded : 1984 Headquarters : Hyderabad, Andhra Pradesh, India

Key people : Anji Reddy, Chairman

GV Prasad, CEO

Revenue : $1.5 billion (May 2007) Net income : $216 million (May 2007) Employees : 8,225

ORIGIN & HISTORY Dr. Reddy's Laboratories Ltd., trading as Dr. Reddy's, founded in 1984 by

Dr. K. Anji Reddy, has become India's second biggest pharmaceutical company. Dr. Anji Reddy had worked in the publicly-owned Indian Drugs and Pharmaceuticals Ltd. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology products.

Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA). By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.

HISTORY CONTIOUS…..By 2007, Dr. Reddy's had six FDA-plants producing active pharmaceutical ingredients in India and seven FDA-inspected and ISO 9001 (quality) and ISO 14001 (environmental management) certified plants making patient-ready medications – five of them in India and two in the UK.[1]

KEY PRODUCTS

Top active pharmaceutical ingredients

• Ciprofloxacin Hydrochloride• Ramipril• Terbinafine HCI • Ibuprofen• Sertaline Hydrochloride • Ranitidine HCI Form 2• Naproxen Sodium • Naproxen• Atorvastatin • Montelukast• Losartan Potassium • Sparfloxacin• Nizatidine • Fexofenadine• Ranitidine Hydrochloride Form 1 • Clopidogrel • Omeprazole • Finasteride• Sumatriptan

PATENTS & PROFITSTop-10 brands in India

• Omez• Nise

• Stamlo• Stamlo Beta

• Enam• Atocor

• Razo

• Reclimet

• Clamp

• Mintop

Board of Directors Dr. Reddy’s Board of Directors comprises eminent individuals from diverse fields. The Board acts with autonomy and independence in

exercising strategic supervision, discharging its fiduciary responsibilities, and in ensuring that the management observes the

highest standards of ethics, transparency and disclosure.WHOLE-TIME DIRECTORS

Dr. K. Anji ReddyChairman

G V PrasadVice Chairman and

Chief Executive Officer

Satish ReddyManaging Director & Chief

Operating Officer

MISSION & VISION

Our purpose

Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company.

As a fully integrated pharmaceutical company, our purpose is to provide affordable and innovative medicines through our three core businesses: • Pharmaceutical Services and Active Ingredients, comprising our Active Pharmaceuticals and Custom Pharmaceuticals businesses; • Global Generics, which includes branded and unbranded generics; and• Proprietary Products, which includes New Chemical Entities (NCEs), Differentiated Formulations, and Generic Biopharmaceuticals.

STRATEGIC ALLAINCES OF DR. REDDY LABORATORIES

THROUGH STRATEGIC ALLAINCES WITH MANY FIRMS DR. REDDY LABORATORIES’S PRIME FOCUS IS CUSTOMER CENTRIC

• The core strengths of our PSAI business are the state-of-the-art infrastructure, resources and skills we are able to offer to our customers:

• Large and diverse product portfolio• Eight FDA-inspected plants and three technology

centers • World class chemistry expertise• Robust, large-scale manufacturing capabilities• Intellectual Property (IP) driven product development

for freedom to operate• Total, seamless supply chain management

Building capabilities exceeding expectationsDeep Manufacturing Expertise

DR. REDDY LABS, have 16 world-class manufacturing facilities of which 9 have a long history of regular USFDA inspections. With an annual capacity of nine billion tablets/ capsules a year, dedicated to servicing the more regulated markets, one of our finished dosages facilities is among the largest in Asia. Our facilities are designed to respond to a wide range of technologies - oral solids, injectibles, topicals, inhalers, cytotoxic, hormonals and other dosage forms.

Likewise our API facilities offer lean manufacturing, adhere to stringent regulatory guidelines and continually drive cost competitiveness. Such manufacturing capabilities and our inherent expertise to navigate intellectual property road blocks make us a preferred partner for some of the world’s leading pharmaceutical companies.

Globally Synchronized Supply Chain

DR. REDDY LABS, put the needs of our partners and customers first. Our globally synchronized supply chain and a comprehensive Information technology platform help us assure customers of timely delivery and superior inventory turns. The uninterrupted success of our customers’ business is our promise.

Globally Synchronized Supply Chain

We put the needs of our partners and customers first. Our globally synchronized supply chain and a comprehensive Information technology platform help us assure customers of timely delivery and superior inventory turns. The uninterrupted success of our customers’ business is our promise.

Quality & Product Responsibility

At Dr. Reddy’s, quality control and quality assurance systems as specified by regulatory requirements in each of the geographies in which we operate. For them, product responsibility extends through the life cycle of the product -- from product development to manufacture to product release to post-launch. We comply with the internationally accepted International Conference on Harmonization (ICH) guidelines in product development and we have independent quality control and quality assurance teams to ensure multi-stage quality compliance

Regulatory Performance

Over the years DR. REDDY LABS built an expertise in understanding the regulatory frameworks of the various countries in which we operate. This has given them a distinctive edge, for ourselves and our customers. They have built a successful track record of timely and extensive approvals. As an example, they are among the leaders in terms of DMFs and ANDAs in the US itself, with more than half of these being Para IV possibilities.

COMMITMENT TO SOCIETY

Dr. Reddy's Pharmaceutical Company has some set values that make it stand out among all pharmaceutical companies. These include: • Quality• Harmony and social

responsibility• Respect for the individual• Collaboration and team work• Innovation and continuous

learning

…….thank you